Yang VC - Search Results

1

Recombinant TAT-gelonin fusion toxin: synthesis and characterization of heparin/protamine-regulated cell transduction.

Shin MC, Zhao J, Zhang J, Huang Y, He H, Wang M, Min KA, Yang VC. Shin MC, et al. Among authors: yang vc. J Biomed Mater Res A. 2015 Jan;103(1):409-419. doi: 10.1002/jbm.a.35188. Epub 2014 Apr 23. J Biomed Mater Res A. 2015. PMID: 24733757 Free PMC article.

2

Poly-L-lysine amplification of protamine immobilization and heparin adsorption.

Zhang Y, Singh VK, Yang VC. Zhang Y, et al. Among authors: yang vc. J Biomed Mater Res. 1998 Nov;42(2):182-7. doi: 10.1002/(sici)1097-4636(199811)42:2<182::aid-jbm3>3.0.co;2-l. J Biomed Mater Res. 1998. PMID: 9773814 Free article.

3

Low molecular weight protamine: a potential nontoxic heparin antagonist.

Byun Y, Singh VK, Yang VC. Byun Y, et al. Among authors: yang vc. Thromb Res. 1999 Apr 1;94(1):53-61. doi: 10.1016/s0049-3848(98)00201-1. Thromb Res. 1999. PMID: 10213181

4

A pH- and ionic strength-responsive polypeptide hydrogel: synthesis, characterization, and preliminary protein release studies.

Markland P, Zhang Y, Amidon GL, Yang VC. Markland P, et al. Among authors: yang vc. J Biomed Mater Res. 1999 Dec 15;47(4):595-602. doi: 10.1002/(sici)1097-4636(19991215)47:4<595::aid-jbm17>3.0.co;2-i. J Biomed Mater Res. 1999. PMID: 10497296 Free article.

5

Low molecular weight protamine: a potent but nontoxic antagonist to heparin/low molecular weight protamine.

Byun Y, Chang LC, Lee LM, Han IS, Singh VK, Yang VC. Byun Y, et al. Among authors: yang vc. ASAIO J. 2000 Jul-Aug;46(4):435-9. doi: 10.1097/00002480-200007000-00013. ASAIO J. 2000. PMID: 10926141

6

ATTEMPTS: a heparin/protamine-based delivery system for enzyme drugs.

Liang JF, Li YT, Song H, Park YJ, Naik SS, Yang VC. Liang JF, et al. Among authors: yang vc. J Control Release. 2002 Jan 17;78(1-3):67-79. doi: 10.1016/s0168-3659(01)00484-9. J Control Release. 2002. PMID: 11772450

7

Poly(glutamic acid) poly(ethylene glycol) hydrogels prepared by photoinduced polymerization: Synthesis, characterization, and preliminary release studies of protein drugs.

Yang Z, Zhang Y, Markland P, Yang VC. Yang Z, et al. Among authors: yang vc. J Biomed Mater Res. 2002 Oct;62(1):14-21. doi: 10.1002/jbm.10219. J Biomed Mater Res. 2002. PMID: 12124782 Free article.

8

ATTEMPTS: a heparin/protamine-based triggered release system for the delivery of enzyme drugs without associated side-effects.

Park YJ, Liang JF, Song H, Li YT, Naik S, Yang VC. Park YJ, et al. Among authors: yang vc. Adv Drug Deliv Rev. 2003 Feb 10;55(2):251-65. doi: 10.1016/s0169-409x(02)00181-3. Adv Drug Deliv Rev. 2003. PMID: 12564979 Review.

9

A less toxic heparin antagonist--low molecular weight protamine.

Liang JF, Zhen L, Chang LC, Yang VC. Liang JF, et al. Among authors: yang vc. Biochemistry (Mosc). 2003 Jan;68(1):116-20. doi: 10.1023/a:1022109905487. Biochemistry (Mosc). 2003. PMID: 12693985 Free article.

10

Low molecular weight protamine as an efficient and nontoxic gene carrier: in vitro study.

Park YJ, Liang JF, Ko KS, Kim SW, Yang VC. Park YJ, et al. Among authors: yang vc. J Gene Med. 2003 Aug;5(8):700-11. doi: 10.1002/jgm.402. J Gene Med. 2003. PMID: 12898639 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

239 results

Search Page

Filters